Keon-il Im
Seoul, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 28 publications
Cytokine-Induced Killer Cell Therapy as a Postremission Strategy in High-Risk Patients Undergoing Autologous Hematopoietic Stem Cell Transplantation: A Prospective Investigator-Initiated Clinical Study.
Journal: Transplantation and cellular therapy
Published: November 10, 2025
Effectiveness and safety of Autologous Virus-Specific T Cell Therapy for Persistent COVID-19 in People with Immunocompromise: A Clinical Trial Study.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: March 23, 2025
Effectiveness and Safety of Autologous Virus-Specific T-Cell Therapy for Persistent COVID-19 in People With Immunocompromise: A Clinical Trial Study.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: March 23, 2025
SARS-CoV-2-Specific T-Cell as a Potent Therapeutic Strategy against Immune Evasion of Emerging COVID-19 Variants.
Journal: International journal of molecular sciences
Published: September 05, 2024
Repeated Infusions of Bone-Marrow-Derived Mesenchymal Stem Cells over 8 Weeks for Steroid-Refractory Chronic Graft-versus-Host Disease: A Prospective, Phase I/II Clinical Study.
Journal: International journal of molecular sciences
Published: May 11, 2024
Mesenchymal stem cells preconditioned with a TLR5 agonist enhanced immunoregulatory effect through M2 macrophage polarization in a murine graft-versus-host disease model.
Journal: International journal of medical sciences
Published: December 11, 2023
TLR5 agonist in combination with anti-PD-1 treatment enhances anti-tumor effect through M1/M2 macrophage polarization shift and CD8+ T cell priming.
Journal: Cancer immunology, immunotherapy : CII
Published: December 07, 2023
The IL-6 signaling pathway contributes critically to the immunomodulatory mechanism of human decidua-derived mesenchymal stromal cells.
Journal: iScience
Published: November 24, 2023
Human mesenchymal stem cells derived from umbilical cord and bone marrow exert immunomodulatory effects in different mechanisms.
Journal: World journal of stem cells
Published: March 20, 2020
Enhancement of Graft-Versus-Host Disease Control Efficacy by Adoptive Transfer of Type 1 Regulatory T Cells in Bone Marrow Transplant Model.
Journal: Stem cells and development
Published: November 02, 2018
Last Updated: 09/26/2026